OCULAR THERAPEUTIX, INC SEC filings

Filings

1. 8-KOCULAR THERAPEUTIX, INCOCUL2d

   OCULAR THERAPEUTIX, INC. loses Chief Strategy Officer

   • Sanjay Nayak resigns as Chief Strategy Officer
   • Effective October 16, 2026
   • Nayak to become CEO of private company
2. 4OCULAR THERAPEUTIX, INCOCUL5d

   Anderman Todd sold shares of OCUL

   • Sold 11,984 shares on 10/08/2026
   • Price range $7.10-$7.45
   • Sold to cover tax obligations

   Todd Anderman, reporting

3. 144OCULAR THERAPEUTIX, INCOCULOct 8

   OCUL files Form 144 by Anderman Todd

   • Filer CIK: 0002039533
   • Shares to sell: 11984
   • Market value: $87315.42

   Todd Anderman, reporting

4. 4OCULAR THERAPEUTIX, INCOCULOct 8

   2 insider filings

   Jeffrey S. Heier, insider filing for OCUL

   Show all 2

   • 4Insider filing for OCULOct 8
   • 4Insider filing for OCULOct 8

   Jeffrey S. Heier, reporting

5. 144OCULAR THERAPEUTIX, INCOCULOct 2

   2 Form 144 notices

   Jeffrey S. Heier, planned sale of OCUL shares

   Show all 2

   • 144Planned insider sale of OCUL sharesOct 2
   • 144Planned insider sale of OCUL sharesOct 2

   Jeffrey S. Heier

6. 4OCULAR THERAPEUTIX, INCOCULSep 2

   Donald Notman, insider filing for OCUL

   Donald Notman, reporting

7. 144OCULAR THERAPEUTIX, INCOCULAug 31

   Donald Notman, planned sale of OCUL shares

   Donald Notman, reporting

8. 4OCULAR THERAPEUTIX, INCOCULAug 26

   4 insider filings

   Peter Kaiser, insider filing for OCUL

   Show all 4

   • 4Insider filing for OCULAug 26
   • 4Insider filing for OCULAug 26
   • 4Insider filing for OCULAug 26
   • 4Insider filing for OCULAug 26

   Peter Kaiser, reporting

9. 144OCULAR THERAPEUTIX, INCOCULAug 24

   4 Form 144 notices

   Sanjay Nayak, planned sale of OCUL shares

   Show all 4

   • 144Planned insider sale of OCUL sharesAug 24
   • 144Planned insider sale of OCUL sharesAug 24
   • 144Planned insider sale of OCUL sharesAug 24
   • 144Planned insider sale of OCUL sharesAug 24

   Sanjay Nayak, reporting

10. S-8OCULAR THERAPEUTIX, INCOCULAug 3

    Employee stock plan registration

11. 10-QOCULAR THERAPEUTIX, INCOCULAug 3

    Quarterly report

12. 8-KOCULAR THERAPEUTIX, INCOCULAug 3

    Current report

13. SCHEDULE 13G/AOCULAR THERAPEUTIX, INCOCULJul 29

    Ownership stake disclosure by BlackRock, Inc. (amended)

    BlackRock, Inc., filed by

14. 4OCULAR THERAPEUTIX, INCOCULJun 18

    Pravin Dugel, insider filing for OCUL

    Pravin Dugel, reporting

15. 4OCULAR THERAPEUTIX, INCOCULJun 12

    7 insider filings

    Charles M Warden, insider filing for OCUL

    Show all 7

    • 4Insider filing for OCULJun 12
    • 4Insider filing for OCULJun 12
    • 4Insider filing for OCULJun 12
    • 4Insider filing for OCULJun 12
    • 4Insider filing for OCULJun 12
    • 4Insider filing for OCULJun 12
    • 4Insider filing for OCULJun 12

    Charles M Warden, reporting

16. 8-KOCULAR THERAPEUTIX, INCOCULJun 12

    Current report

17. 4OCULAR THERAPEUTIX, INCOCULJun 5

    Nadia Waheed, insider filing for OCUL

    Nadia Waheed, reporting

18. 144OCULAR THERAPEUTIX, INCOCULJun 3

    Nadia Waheed, planned sale of OCUL shares

    Nadia Waheed, reporting

19. 4OCULAR THERAPEUTIX, INCOCULMay 28

    4 insider filings

    Pravin Dugel, insider filing for OCUL

    Show all 4

    • 4Insider filing for OCULMay 28
    • 4Insider filing for OCULMay 28
    • 4Insider filing for OCULMay 28
    • 4Insider filing for OCULMay 28

    Pravin Dugel, reporting

20. 144OCULAR THERAPEUTIX, INCOCULMay 26

    4 Form 144 notices

    Sanjay Nayak, planned sale of OCUL shares

    Show all 4

    • 144Planned insider sale of OCUL sharesMay 26
    • 144Planned insider sale of OCUL sharesMay 26
    • 144Planned insider sale of OCUL sharesMay 26
    • 144Planned insider sale of OCUL sharesMay 26

    Sanjay Nayak, reporting

21. SCHEDULE 13G/AOCULAR THERAPEUTIX, INCOCULMay 15

    Ownership stake disclosure by Deep Track Capital, LP (amended)

    Deep Track Capital, LP, filed by

22. 10-QOCULAR THERAPEUTIX, INCOCULMay 5

    Quarterly report

23. 8-KOCULAR THERAPEUTIX, INCOCULMay 5

    Current report

24. DEFA14AOCULAR THERAPEUTIX, INCOCULApr 30

    Additional proxy materials

25. DEF 14AOCULAR THERAPEUTIX, INCOCULApr 30

    Proxy statement

26. ARSOCULAR THERAPEUTIX, INCOCULApr 30

    Annual report to shareholders

27. 4OCULAR THERAPEUTIX, INCOCULApr 13

    Pravin Dugel, insider filing for OCUL

    Pravin Dugel, reporting

28. SCHEDULE 13G/AOCULAR THERAPEUTIX, INCOCULMar 27

    Ownership stake disclosure by VANGUARD GROUP INC (amended)

    VANGUARD GROUP INC, filed by

29. 8-KOCULAR THERAPEUTIX, INCOCULFeb 27

    Current report

30. 4OCULAR THERAPEUTIX, INCOCULFeb 25

    Pravin Dugel, insider filing for OCUL

    Pravin Dugel, reporting

Older filings on EDGAR